EP1237608A2 - Behälter zur vereinfachung der förderung von pulver - Google Patents

Behälter zur vereinfachung der förderung von pulver

Info

Publication number
EP1237608A2
EP1237608A2 EP00989270A EP00989270A EP1237608A2 EP 1237608 A2 EP1237608 A2 EP 1237608A2 EP 00989270 A EP00989270 A EP 00989270A EP 00989270 A EP00989270 A EP 00989270A EP 1237608 A2 EP1237608 A2 EP 1237608A2
Authority
EP
European Patent Office
Prior art keywords
receptacle
cavity
extraction tube
bottom end
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP00989270A
Other languages
English (en)
French (fr)
Other versions
EP1237608B2 (de
EP1237608B1 (de
Inventor
Steve Paboojian
Carlos Schuler
Andrew Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Inhale Therapeutics Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22627201&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1237608(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inhale Therapeutics Systems Inc filed Critical Inhale Therapeutics Systems Inc
Priority to EP06015709A priority Critical patent/EP1726323B1/de
Priority to SI200030926T priority patent/SI1237608T1/sl
Publication of EP1237608A2 publication Critical patent/EP1237608A2/de
Application granted granted Critical
Publication of EP1237608B1 publication Critical patent/EP1237608B1/de
Publication of EP1237608B2 publication Critical patent/EP1237608B2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/06—Containers or packages with special means for dispensing contents for dispensing powdered or granular material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/06—Gas or vapour producing the flow, e.g. from a compressible bulb or air pump
    • B05B11/062—Gas or vapour producing the flow, e.g. from a compressible bulb or air pump designed for spraying particulate material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/002—Details of inhalators; Constructional features thereof with air flow regulating means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A61M15/0036—Piercing means hollow piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B7/00—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas
    • B05B7/14—Spraying apparatus for discharge of liquids or other fluent materials from two or more sources, e.g. of liquid and air, of powder and gas designed for spraying particulate materials
    • B05B7/1404—Arrangements for supplying particulate material
    • B05B7/1413—Apparatus to be carried on or by a person, e.g. by hand; Apparatus comprising a container fixed to the discharge device
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes, or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
    • B65D75/366—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed and forming one compartment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/07—General characteristics of the apparatus having air pumping means
    • A61M2205/071—General characteristics of the apparatus having air pumping means hand operated
    • A61M2205/073—Syringe, piston type
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2575/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D2575/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by association or interconnecting two or more sheets or blanks
    • B65D2575/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D2575/36—One sheet or blank being recessed and the other formed or relatively stiff flat sheet material, e.g. blister packages
    • B65D2575/361—Details
    • B65D2575/362—Details with special means for gaining access to the contents

Definitions

  • This invention relates generally to the field of drug delivery, and in particular to the pulmonary delivery of powdered medicaments. More specifically, the invention relates to techniques for extracting powdered medicaments from receptacles during the aerosolizing process.
  • pulmonary delivery where a drug dispersion or aerosol is inhaled by the patient to permit the active drug within the dispersion to reach the distal or alveolar regions of the lung.
  • Pulmonary drug delivery has shown to be particularly promising because certain drugs have been found to readily absorb within the blood circulation.
  • pulmonary delivery may be a useful approach for proteins and polypeptides that are difficult to deliver by other routes of administration.
  • the high pressure gas stream then draws air through the receptacle and into the extraction tube.
  • the air drawn through the receptacle extracts the powder where it joins with the high pressure gas stream to form the aerosol.
  • This invention is related to alternative ways to extract powder from receptacles that store the powder.
  • the invention also relates to the design of such receptacles to facilitate removal of the powder.
  • the invention provides an exemplary receptacle for holding fine powders.
  • the receptacle comprises a receptacle body that defines an enclosed cavity for holding the powder.
  • the receptacle body has a top end and a bottom end, and the cavity is configured to facilitate extraction of substantially all of the powder when air or another gas is drawn through the cavity.
  • the bottom end of the receptacle body includes a raised central region that extends upwardly into the cavity. Such a configuration is advantageous in that it permits the flow of air to remain adjacent to an inner wall of the cavity until being drawn into an extraction tube.
  • the curved interior wall in combination with the raised central region forms a generally semi-toroidal geometry in the cavity.
  • the walls may be curved to form a "bow tie" configuration.
  • a portion of the bottom end of the receptacle may be flat in geometry to facilitate convenient resting of the receptacle on a flat surface and accurate vertical positioning of the receptacle.
  • the receptacle body may comprise a pair of opposing curved walls and a pair of opposing generally planar walls that at least partially form the cavity.
  • the receptacle body may further include a tab that extends from the cavity to facilitate handling of the receptacle, e.g., such as when inserting the receptacle into an aerosolizing device.
  • the invention further provides an exemplary method for aerosolizing a powdered medicament.
  • the method utilizes a receptacle having an enclosed cavity for holding the powder.
  • the receptacle further includes a raised central region that extends upwardly into the cavity. According to the method, a bottom end of an extraction tube is inserted into the cavity such that the bottom end of the extraction tube is aligned with the raised central region and is spaced above the bottom end of the receptacle.
  • Vents are formed in the top end of the receptacle about a periphery of a cavity, and a gas stream is flowed through at least a portion of the extraction tube to draw air through the vents and then through the cavity to move the powder in the cavity into the extraction tube where the powder is entrained in the high pressure gas stream to form an aerosol.
  • Use of the raised central region is advantageous in that it channels or funnels the air toward the extraction tube to prevent powder from remaining in the center of the cavity.
  • the receptacle has one or more curved interior walls.
  • the air flows along the wall along substantially the entire length of the cavity to remove substantially all powder from the receptacle.
  • the momentum of the flowing air is changed which causes the air flow to stay adjacent the wall, causing powder adjacent the wall to be drawn into the extraction tube.
  • the air drawn by the gas stream flows through a flow area that becomes progressively smaller. In this way, the air is accelerated as it flows through the receptacle and into the extraction tube to further assist in removing substantially all of the powder from the receptacle.
  • a hole is pierced through the top end of the receptacle to permit the extraction tube to be inserted into the cavity through the hole in the top end.
  • the gas stream may be introduced into the extraction tube at a location spaced apart from the bottom end of the extraction tube. Further, the gas stream may be introduced at an acute angle relative to a central axis of the extraction tube. In this way, the area of flow through the receptacle and the extraction tube may be controlled to accelerate the air through the receptacle.
  • a hole may be formed in the bottom end of the receptacle body, and the gas stream may be flowed through the hole in the bottom end and then through the extraction tube, with outside air being drawn into the cavity through one or more vents to move the powder into the extraction tube.
  • a flow insert may be provided to control spacing of the extraction tube relative to the receptacle. In this way, the area of flow through the receptacle and the extraction tube may be controlled to accelerate the air through the receptacle.
  • an amount of pressurized gas is released to produce a high pressure gas stream that is utilized to extract the powder from the receptacle.
  • the gas stream may be produced by the patient's own inhalation, i.e. breath actuation.
  • the invention provides a method for aerosolizing a powdered medicament that utilizes a receptacle having an enclosed cavity for holding the powder.
  • An extraction tube is inserted into the cavity such that a bottom end of the extraction tube is spaced above the bottom end of the receptacle. Vents are formed in the top end of the receptacle and a high pressure gas stream is flowed through at least a portion of the extraction tube to draw air through the vents and then into the cavity to remove the powder.
  • a gas stream created by the patient's own inhalation may be flowed through the extraction tube to remove the powder.
  • the area of flow is progressively reduced to accelerate the flow of air through the receptacle.
  • the vents may form a first flow area, and a gap between the extraction tube and the bottom end of the receptacle may define a second flow area. Further, a cross-section of the extraction tube may define a third flow area. The first flow area is constructed to be larger than the second flow area, and the second flow area is constructed to be larger than the third flow area.
  • the receptacle may include a curved interior wall and a raised central region that extends upwardly into the cavity so that a generally laminar flow of air may be produced along the wall in a manner similar to that previously described.
  • the invention further provides an exemplary method for aerosolizing a powder that utilizes a receptacle having a cavity that contains the powder.
  • a bottom end of an extraction tube is inserted into the cavity such that the bottom end of the extraction tube is spaced above the bottom end of the receptacle.
  • At least one vent is formed in the cavity, and a hole is formed in the bottom of the cavity such that the hole is generally aligned with the bottom end of the extraction tube.
  • a gas stream is then flowed through the hole in the bottom end of the receptacle and then through the extraction tube to cause air to be drawn through the vent and then through the cavity to move powder in the cavity into the extraction tube where the powder is entrained in the gas stream to form an aerosol.
  • the aerosolized powder is captured in a capture chamber where it is available for inhalation by a patient.
  • the method may utilize various features described in connection with other embodiments of the invention.
  • the receptacle may include a raised central region that extends upwardly into the cavity and is generally aligned with the extraction tube.
  • multiple vents may be formed in the top of the receptacle about a periphery of a cavity to draw air into substantially all of the cavity.
  • Tabs or foils may also be formed in the top of the receptacle that extend into the cavity to create a vortex within the cavity as the air flows through the cavity.
  • the gas stream may be produced by releasing an amount of gas from a pressured gas source, or may be produced by the patient's own inhalation.
  • an apparatus for aerosolizing a powdered medicament.
  • the apparatus comprises a housing having a holder for holding a receptacle having a cavity that contains the powder.
  • a piercing mechanism is provided to pierce a hole in a bottom end of the receptacle, and a vent forming mechanism is provided to form multiple vents in the top of the receptacle.
  • An extraction tube is further provided and may be placed into the cavity so as to be spaced above the bottom end of the receptacle and to be aligned with the hole in the bottom end.
  • a pressure source or the patient's own inhalation may be utilized to produce a gas stream that is flowed through the hole in the bottom end of the receptacle and into the extraction tube.
  • the vent forming mechanism may be configured to produce multiple vents that are spaced about a periphery of the receptacle.
  • a system for aerosolizing a powdered medicament.
  • the system comprises at least one receptacle that defines an enclosed cavity.
  • the receptacle further includes a raised central region that extends upwardly into the cavity.
  • An aerosolization apparatus is further provided having a holder for holding the receptacle.
  • the aerosolizing apparatus further includes an extraction tube that is insertable into the cavity, a vent forming device to form multiple vents in the top end of the receptacle about a periphery of the cavity, and a pressure source for producing a high pressure gas stream within at least a portion of the extraction tube.
  • the patient's own inhalation may be used to produce a gas stream.
  • a flow insert may be provided to control spacing of the extraction tube relative to the receptacle. Further, the flow insert in combination with the vents and the extraction tube may be employed to accelerate the flow of air through the receptacle.
  • the vents may be configured to form a first flow area, and a gap between the extraction tube and the bottom end of the receptacle may define a second flow area. A cross-section of the extraction tube may define a third flow area.
  • the holder may be configured to move the receptacle relative to the bottom end of the extraction tube, or vice versa, such that the first flow area is greater than the second flow area, and the second flow area is greater than the third flow area.
  • curved tabs or foils may be preformed in the top end of the receptacle body to create a vortex within the cavity as the air flows through the cavity. In this way, removal of substantially all the powder from the receptacle is facilitated.
  • a portion of the bottom end of the receptacle may be flat in geometry to facilitate its placement onto the holder.
  • the receptacle may have a preformed central hole and vents about the periphery of the cavity.
  • a cover may be removably attached to the top end of the receptacle. In this way, after the receptacle has been inserted into the aerosolizing apparatus, the cover may be pulled from the receptacle to permit the extraction tube to be inserted into the central hole and to expose the vents.
  • FIG. 1 is a top view of one embodiment of a receptacle for holding a powder according to the invention.
  • Fig. 2 is a cross sectional side view of the receptacle of Fig. 1, taken along lines 2-2.
  • Fig. 3 is a perspective view of the receptacle of Fig. 1 showing vents formed in a top end and an extraction tube that has been inserted into the top end according to one embodiment of the invention.
  • Fig. 4 is a schematic side view of an exemplary method for extracting powder from the receptacle of Fig. 3 according to the invention.
  • Fig. 5 is a partial top view of another embodiment of a receptacle having curved tabs or foils to produce a vortex in the receptacle when extracting powder according to the invention.
  • Fig. 6 is a partial cross sectional side view of one of the tabs of the receptacle of Fig. 5.
  • Fig. 7 is a top view of an alternative embodiment of a receptacle according to the invention.
  • Fig. 8 A is a cross sectional side view of the receptacle of Fig. 7 taken along lines A-A.
  • Fig. 8B is a cross sectional side view of the receptacle of Fig. 7 taken along lines B-B.
  • Fig. 9 is a perspective view of a receptacle into which an extraction tube is inserted and illustrates the various flow areas through which the air flows when extracting the powder from the receptacle according to the invention.
  • Fig. 10 is a schematic side view of one embodiment of an aerosolizing device that may be employed to aerosolize a powder according to the invention.
  • Fig. 11 is a schematic side view of a receptacle and an extraction tube and illustrates an alternative technique for extracting the powder according to the invention.
  • Fig. 12 is a schematic side view of an alternative embodiment of an aerosolizing device according to the invention.
  • Fig. 13 is a top view of still another alternative embodiment of a receptacle having a removable cover according to the invention.
  • Fig. 14 is a cross sectional side view of the receptacle of Fig. 13.
  • Fig. 15 is a schematic side view of a breath actuated aerosolizing device according to the invention.
  • the invention provides exemplary techniques and equipment for extracting powder that is held within a receptacle, typically within a sealed cavity.
  • the powder extracted is entrained in a high pressure gas stream to aerosolize the powder so that it will be suitable for inhalation by a patient.
  • the invention may be utilized with essentially any type of receptacle within which the powder is sealed.
  • one type of receptacle that may be utilized with the invention are widely available "blister packs". Examples of other types of receptacles are described in U.S. Patent No. 5,740,794, previously incorporated by reference.
  • the powders of the invention may be extracted by creating an opening or access way into the receptacle and then flowing air or other gases through the receptacle to move the powder out of the access way.
  • one or more vents may also be created in the receptacle to facilitate the flow of air through the receptacle.
  • One exemplary way to draw air through the receptacle is by use of an extraction tube that is inserted into the cavity.
  • a high pressure gas stream is flowed through at least a portion of the extraction tube to cause air in the receptacle to be drawn into the bottom end of the extraction tube where the powder is entrained in the high pressure gas stream to form an aerosol.
  • Examples of techniques that employ the use of such an extraction tube are described in U.S. Patent No. 5,740,794, previously incorporated by reference. Further, a variety of techniques may be employed to create the high pressure gas stream to cause the air to be drawn through the receptacle. For example, various techniques for producing the high pressure gas stream are described in U.S. Patent No. 5,740,794 and copending U.S. Patent Application Serial Nos. 09/004,558, 09/312,434, 60/136,518 and 60/141,793, previously incorporated herein by reference. Gases that may be used to produce the gas stream include air, CO , HFCs, CFCs, and the like.
  • the high pressure gas stream may be introduced into the extraction tube at a location that is spaced apart from the bottom end.
  • the high pressure gas stream may be introduced into the extraction tube at an acute angle as described generally in U.S. Patent No. 5,740,794, previously incorporated by reference.
  • a hole may be formed in the bottom end of the receptacle along with one or more vents, and the extraction tube inserted into the top end of the receptacle so that it is generally aligned with the hole. The high pressure gas stream may then be flowed through the hole and into the extraction tube to cause air to be drawn through the vents, through the receptacle and into the bottom end of the extraction tube.
  • the invention may utilize a patient's own inhalation to produce a gas stream.
  • the invention may utilize a mouthpiece over which the patient's mouth is placed. As the patient inhales, a vacuum is created to produce a gas stream that flows through the receptacle as described above.
  • a variety of schemes may be employed, alone or in combination, to facilitate the extraction of the powder using air flowing through the receptacle.
  • one technique employs the use of air or other gases to uniformly "scrub" the sides of the cavity. More specifically, the air may be flowed adjacent an interior wall or walls until the air exits the receptacle through the extraction tube. In this way, a shear stress is provided along substantially the entire length of the interior wall to assist in removing any powder that adheres to the wall so that it may be moved into the extraction tube.
  • the walls may be constructed with a variety of geometries to facilitate a laminar flow across the walls so that the flow will not become separated from the walls as it flows through the receptacle.
  • one convenient way to form the walls is to provide them with a degree of curvature so that they continuously curve up to the extraction tube.
  • Such a continuous curved surface allows for a laminar flow along substantially the entire length of the walls and up to the extraction tube.
  • the curvature of the walls also tends to induce instabilities that are manifested as a plurality of counter-rotating vortices, sometimes referred to as Taylor-Goertler vortices, having axes of rotation locally parallel to the curved walls. These vortices serve to scrub the walls of powder.
  • the receptacle may include a raised region at a center of the receptacle so that the walls slope up to the extraction tube. In this way, no dead space is provided in the middle of the receptacle and the flow remains adjacent to the walls until exiting through the extraction tube.
  • Another technique to facilitate removal of the powder is to accelerate the flow of air through the receptacle.
  • One convenient way to accelerate the air flow is to progressively decrease the area through which the air passes as it flows through the receptacle and out of the extraction tube. By progressively reducing the flow area, the air is accelerated as it flows through the receptacle and into the extraction tube.
  • Still another technique for facilitating the removal of the powder is to create a vortex in the cavity to permit the air to sweep the sides of the receptacle as it spins through the cavity and up into the extraction tube.
  • curved edges, tabs or foils may be formed in the top end of the receptacle to initiate the vortex when air is drawn into the receptacle.
  • the receptacles may be constructed to have preformed holes and/or vents. In this way, the top surface of the receptacle does not need to be pierced when inserting the extraction tube or forming the vents.
  • a removable cover may be placed on top of the receptacle. After insertion into an aerosolizing apparatus, the cover may be pulled from the receptacle to expose the holes and/or vents. The extraction tube may then be inserted into the receptacle and the powder extracted as described herein.
  • Receptacle 10 comprises a receptacle body 12 having a top end 14 and a bottom end 16 (see Fig. 2).
  • a tab 18 may be provided to facilitate handling of receptacle 10.
  • Receptacle body 12 defines a cavity 20 into which a powder is sealed.
  • receptacle body 12 may be constructed from essentially any type of material that is compatible with the powder held within cavity 20. Examples of materials that may be used include metals, such as aluminum, composites, plastics, and the like.
  • One convenient way to construct receptacle 10 is to provide a thin strip of metal or composite and then pressing cavity 20 using a dye. Another thin strip of metal may then be attached to the strip having the cavity to enclose and seal the cavity. Conveniently, ultrasonic welding or heat sealings may be employed to adhere the two metal strips together.
  • a number of receptacles may be formed as a single string for multi-dose aerosolizers.
  • Cavity 20 has a generally circular outer periphery 22 and is formed of a continuously curved wall 24 that forms a raised central region 26 at or near a center of the receptacle. In this way, a generally semi-toroidal interior is formed.
  • Extraction tube 28 is shown inserted into cavity 20.
  • Extraction tube 28 has a bottom end 30 that is generally aligned with raised central region 26 when inserted into receptacle 10.
  • bottom end 30 of extraction tube 28 may include a sharpened edge to facilitate its entry into cavity 20.
  • a preformed hole may be formed in top end 14 to permit entry of extraction tube 28 into cavity 20.
  • Bottom end 30 is positioned so that it is spaced apart from bottom end 16 of cavity 20. In this way, a gap is provided between bottom end 30 and bottom end 16 to permit air to flow between the gap.
  • Also shown in Fig. 3 are a plurality of vents 32 that are formed about periphery 22.
  • vents 32 may be formed such that they are spaced close to each other in an attempt to form an annulus about periphery 22. In this way, air may be introduced into cavity 20 about essentially the entire periphery 22.
  • a high pressure gas stream (not shown) is flowed past a portion of extraction tube 28 at a location spaced above bottom end 30 as described generally in U.S. Patent No. 5,740,794, previously incorporated by reference. This causes air to be drawn into receptacle 10 through vents 32 as illustrated by the arrows. The air is flowed through cavity 20 until entering bottom end 30 where it proceeds through extraction tube 28. Eventually, the air containing the powder is joined with the high pressure gas stream that deagglomerates the powder and entrains the powder in the gas stream to form an aerosol.
  • wall 24 has a continuous curvature so that the air flowing through cavity 20 remains generally adjacent wall 24 with a laminar flow. In this way, a shear stress is created along substantially the entire length of wall 24 to remove any adhered powder along wall 24. Further, central region 26 directs the air up to bottom end 30 so that essentially no dead volume exists within cavity 20. In this manner, substantially all the powder is drawn into extraction tube 30. It will be appreciated that the size of cavity 20 as well as the degree of curvature of wall 24 may be varied depending on a variety of features, including, for example, the volume and rate of air flow through cavity 20, the amount and type of powder held within cavity 20, and the like. Referring now to Figs.
  • Receptacle 34 comprises a receptacle body 36 that forms a cavity 38 (shown in phantom line). Cavity 38 has a generally circular outer periphery 40 and may optionally include a raised central region as described in connection with other embodiments. Formed in a top end 42 of receptacle body 36 are a plurality of vents 44. A central hole 46 is also formed in top end 42 and is configured to receive an extraction tube. In this way, air may be drawn through vents 44, through cavity 38, and into the extraction tube where it is extracted from the receptacle in a manner similar to that previously described with other embodiments.
  • receptacle 34 includes curved foils 48 at each of the vents 44.
  • foils 48 extend into cavity 38 so as to produce a vortex within cavity 38 when air is drawn in through vents 44. This is illustrated generally by the arrows in Fig. 5.
  • the vortex results in an acceleration of the air to further assist in removing powder from the receptacle.
  • large powder agglomerates within cavity 38 may be caught in the vortex and thrown radially outward because of centripetal acceleration coincident with their larger mass relative to smaller powder particles. In this way, the larger agglomerates are statistically more likely to strike the side of the tube to induce deagglommeration.
  • Figs. 7, 8A and 8B illustrate another embodiment of a receptacle 50.
  • Receptacle 50 comprises a receptacle body 52 having a top end 54, a bottom end 56 and a tab 58.
  • Receptacle body 52 defines a cavity 60 into which a powder is held.
  • Cavity 60 is defined by two side walls 62 and two end walls 64 to form a "bow tie" configuration.
  • a raised central region 66 extends up into cavity 60 in a manner similar to raised central region 26 of receptacle 10.
  • an extraction tube (not shown) may be inserted through top end 54 and aligned above raised central region 66 in a manner similar to that previously described in connection with receptacle 10.
  • Vents may then be formed in top end 54 adjacent curved walls 64. In this manner, air will be drawn through the vents and along curved wall 64 where the air will be tunneled by raised central region 66 into the bottom end of the extraction tube. By providing curved walls 64, the air flow will tend to flow along the walls to assist in removing powder that adheres to the walls in a manner similar to that previously described in connection with receptacle 10.
  • FIG. 9 illustrates one technique for accelerating the flow of air through the cavity.
  • a receptacle 68 comprising a receptacle body 70 having a top end 72 and a bottom end 74.
  • Receptacle body 68 forms a cavity 76 that is defined by an interior wall 78.
  • Cavity 76 may be configured to be generally open or may have a raised central region as previously described in connection with other embodiments.
  • a plurality of vents 79 are formed in top end 72 about a periphery of cavity 76.
  • a center hole 80 is also provided in top end 72 to permit an extraction tube 82 to be inserted into cavity 76 as shown.
  • Extraction tube 82 has a bottom end 84 and a top end 86.
  • extraction tube 82 may have a reduced cross sectional area at top end 86 to facilitate aerosolization of the powder as described generally in U.S. Patent No. 5,740,794, previously incorporated by reference.
  • a high pressure gas stream may be flowed past a portion of extraction tube 82 at a location spaced apart from bottom end 84 in a manner similar to that previously described.
  • the high pressure gas stream may be flowed through a hole in bottom end 74 and then into extraction tube 82, as described hereinafter. In either case, the use of such a high pressure gas stream causes air to be drawn into cavity 76 through vents 79 where the powder is moved into extraction tube 82 through its bottom end 84 where it is entrained in the high pressure gas stream and aerosolized.
  • vents 79 forms a flow area A,.
  • areas A form a total input flow area
  • AS the air flows through extraction tube 82 the flow area is restricted near top end 86 as shown. This area is the cross sectional area Ao of the extraction tube.
  • areas Ai, A G and Ao may be configured such that Ai > A G > Ao.
  • Apparatus 90 comprises a base 92 that forms a housing for various components of apparatus 90. Enclosed in base 92 is a holder 94 for holding a receptacle. For convenience of illustration, receptacle 10 of Fig. 1 is shown held within base 92.
  • a button 96 is provided on holder 94 to permit holder 94 to move up and down within base 92 as indicated by the arrows.
  • holder 94 has a generally flat surface.
  • receptacle body 12 may be included with a flat portion on bottom end 16 to facilitate its placement onto holder 94.
  • holder 94 may be constructed to have different geometries to facilitate holding of receptacle 10, as well as to facilitate introduction and removal of receptacle 10.
  • an aerosolizing mechanism 98 Positioned above receptacle 10 is an aerosolizing mechanism 98 that includes an extraction tube 100 that is insertable into cavity 20 of receptacle 10.
  • a bottom end 102 of extraction tube 100 may include a sharpened edge or other piercing structure to form a hole in the top end of receptacle 10 to facilitate its introduction into cavity 20.
  • Joining extraction tube 100 at an acute angle relative to a central axis of extraction tube 100 (and relative to bottom end 102) are a pair of channels 104.
  • a pressure source 106 is employed to produce a high pressure gas stream within channels 104. The high pressure gas stream is introduced into extraction tube 100 to cause air to be drawn into bottom end 102 from cavity 20 as described generally in U.S. Patent No.
  • Pressure source 106 may be any one of a variety of pressure sources, including manually activated pistons, compressed gases, fluorocarbons, and the like as described generally in the patents and patent applications previously incorporated herein by reference. Hence, it will be appreciated that pressure source 106 is merely being shown schematically for convenience of illustration. Although not shown, an actuating mechanism may be employed to release the pressurized gas from pressure source 106 when a patient is ready to produce the aerosolized medicament. Aerosolization mechanism 98 includes a bottom end 108 that serves as a stop or a flow insert to control the gap between bottom end 102 of extraction tube 100 relative to bottom end 16 of receptacle 10.
  • Capture chamber 112 is configured to capture the aerosolized medicament exiting extraction tube 100 in a manner similar to that described in connection with the patents and patent applications incorporated herein by reference. Capture chamber 112 includes a mouthpiece 114 through which the patient may inhale the captured medicament.
  • apparatus 90 may be employed to aerosolize a medicament by inserting receptacle 10 into base 92.
  • Holder 94 is then raised to insert extraction tube 102 into cavity 20 and to cause piercing elements 110 to form vents in receptacle 10.
  • Pressure source 106 is actuated to release an amount of pressurized gas which causes air to be drawn into and through the vents and along the walls of cavity 20 until entering into extraction tube 100.
  • the powder As the powder is moved into extraction tube 100, it encounters the high pressure gas stream which deagglomerates the powder and ejects the powder into capture chamber 112 in an aerosolized form.
  • holder 94 is shown to move vertically upward, it will be appreciated that extraction tube 100 and/or piercing elements 110 may be configured to be moved downward to be inserted into cavity 20.
  • alternative aerosolizing mechanisms 98 may be employed as described herein.
  • a receptacle 116 having a top end 118 and a bottom end 120.
  • Receptacle 116 includes a cavity 122 having a raised central region 124.
  • a plurality of vents 126 are formed in top end 118 to permit air to be drawn into cavity 122.
  • An extraction tube 128 is inserted into cavity 122, with a bottom end 130 being spaced apart from raised central region 124 as shown.
  • a bottom hole 132 is formed in bottom end 120 of receptacle 116.
  • a high pressure gas stream may be flowed through bottom hole 132 and then through bottom end 130 of extraction tube 128, as shown by the arrows.
  • air is drawn through vents 126 and through cavity 122 where it enters bottom end 130 of extraction tube 128 as shown by the arrows.
  • Shown schematically in Fig. 12 is an aerosolizing apparatus 134 that may be employed to aerosolize a powdered medicament using the techniques just described in connection with Fig. 11.
  • Apparatus 134 comprises a base 136 having a holder 138 for holding a receptacle 140.
  • Holder 138 includes a knob 142 to permit receptacle 140 to be moved up and down as shown by the arrows.
  • an extraction tube 144 having a bottom end 146. By moving knob 142, extraction tube 144 may be inserted into receptacle 140 as shown. Alternatively, extraction tube 144 may be constructed to be movable so that it may be moved into receptacle 140.
  • Pressure source 148 and/or introduction tube 150 may be moved vertically upward as illustrated by the arrows to pierce receptacle 140 and insert introduction tube 150 into or adjacent to receptacle 140. An amount of pressurized gas may then be released from pressure source 150 where it flows through the hole in the bottom end of receptacle 140 and into bottom end 146 of extraction tube 144. As one alternative, holder 142 may be lowered while pressure source 148 is kept stationary to form the hole in the bottom end of receptacle 140.
  • a piercing mechanism may be employed to form one or more vents in receptacle 140 (or receptacle 140 may include pre-formed vents). In this way, outside air may flow into the receptacle through the vents to assist in moving powder into tube 144.
  • a capture chamber 152 Positioned on base 136 is a capture chamber 152 having a mouthpiece 154.
  • receptacle 140 may be placed into holder 138 and extraction tube 144 inserted into receptacle 140.
  • a hole may then be formed in the bottom end of receptacle 140 and a pressurized gas from pressure source 148 released to cause a high pressure gas stream to flow through extraction tube 144. In so doing, air is drawn into and through the receptacle and into extraction tube 144 where the powder is aerosolized and ejected into capture chamber 152.
  • Receptacle 156 comprises a receptacle body 158 having a top end 160 and a bottom end 162.
  • Receptacle body 158 forms a cavity 164 that holds a powder 166.
  • Extending from cavity 164 is a tab 168 to facilitate handling of the receptacle.
  • Formed about a periphery of cavity 164 are a plurality of vents 170 that extend through top end 160.
  • Extending through top end 160 at a center of cavity 164 is a hole 172 that is adapted to receive an extraction tube (not shown) in a manner similar to that described with previous embodiments.
  • cover 174 Secured to top end 160 at a location above cavity 164 is a cover 174.
  • Cover 174 is secured to top end 160 in a manner such that vents 170 and hole 172 is covered to seal powder 166 within cavity 164.
  • cavity 164 includes a raised central region 176.
  • cavity 164 may be constructed to have essentially any geometry.
  • Cover 174 is folded over itself and extends back over tab 168. In this way, cover 174 will generally extend outside of an aerosolization apparatus. As such, when the user is ready to aerosolize the medicament, receptacle 156 is inserted into the aerosolization apparatus and cover 174 is pulled from top end 160. In this way, vents 170 and hole 172 are exposed.
  • FIG. 15 Shown schematically in Fig. 15 is an aerosolizing apparatus 200 that may be employed to aerosolize a powdered medicament using a gas flow created by the patient's own inhalation.
  • Apparatus 200 comprises a base 202 having a holder 204 for holding a receptacle 206, which is representative of any of the receptacles described herein.
  • Holder 204 includes a knob 208 to permit receptacle 206 to be moved up and down as shown by the arrows.
  • extraction tube 210 having a bottom end 212.
  • extraction tube 210 may be inserted into receptacle 206 as shown.
  • extraction tube 210 may be constructed to be movable so that it may be moved into receptacle 206.
  • a piercing mechanism 214 may be positioned below holder 204 to permit a hole to be pierced in the bottom of receptacle 206 when knob 208 is lowered.
  • a mouthpiece 216 Positioned on top of base 202 is a mouthpiece 216 over which a patient's mouth may be placed when ready to receive a dose of medication.
  • receptacle 206 is placed into base 202 so as to be resting within holder 204. Knob 208 is then lowered to pierce a hole in the bottom of receptacle 206. Knob 208 is then raised to insert bottom end 212 of extraction tube 210 into the top of receptacle 206 in a manner similar to that described with other embodiments.
  • the patient then places his or her mouth over mouthpiece 216 and inhales. This causes air to be drawn through the hole in the bottom of receptacle 206 and draws air through vents in the top end of receptacle 206 in a manner similar to other embodiments described herein.
  • the powder drawn into extraction tube 210 then flows upward through mouthpiece 216 and into the patient's lungs.
  • extraction tube 210 may have one or more bends 218 to facilitate powder deagglomeration as the power passes through extraction tube 210.
  • one or more obstacles 220 may be placed into extraction tube 210 to facilitate powder deagglomeration. Further, it will be appreciated that bends and obstacles may be provided in the extraction tubes of the other aerosolization devices described herein.
EP00989270A 1999-12-17 2000-12-15 Behälter zur vereinfachung der förderung von pulver Expired - Lifetime EP1237608B2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06015709A EP1726323B1 (de) 1999-12-17 2000-12-15 Behälter zur Vereinfachung der Förderung von Pulver
SI200030926T SI1237608T1 (sl) 1999-12-17 2000-12-15 Posoda za pospeseno izlocanje praskov

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17231799P 1999-12-17 1999-12-17
US172317P 1999-12-17
PCT/US2000/034037 WO2001043529A2 (en) 1999-12-17 2000-12-15 Receptacles to facilitate the extraction of powders

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP06015709A Division EP1726323B1 (de) 1999-12-17 2000-12-15 Behälter zur Vereinfachung der Förderung von Pulver
EP06015709.6 Division-Into 2006-07-27

Publications (3)

Publication Number Publication Date
EP1237608A2 true EP1237608A2 (de) 2002-09-11
EP1237608B1 EP1237608B1 (de) 2006-11-29
EP1237608B2 EP1237608B2 (de) 2010-05-19

Family

ID=22627201

Family Applications (2)

Application Number Title Priority Date Filing Date
EP00989270A Expired - Lifetime EP1237608B2 (de) 1999-12-17 2000-12-15 Behälter zur vereinfachung der förderung von pulver
EP06015709A Expired - Lifetime EP1726323B1 (de) 1999-12-17 2000-12-15 Behälter zur Vereinfachung der Förderung von Pulver

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP06015709A Expired - Lifetime EP1726323B1 (de) 1999-12-17 2000-12-15 Behälter zur Vereinfachung der Förderung von Pulver

Country Status (17)

Country Link
US (3) US6679256B2 (de)
EP (2) EP1237608B2 (de)
JP (1) JP2003516780A (de)
KR (1) KR20020071888A (de)
AT (2) ATE499131T1 (de)
AU (2) AU782677B2 (de)
CA (1) CA2393615C (de)
CY (1) CY1105993T1 (de)
DE (2) DE60032173T3 (de)
DK (1) DK1237608T3 (de)
ES (2) ES2363713T3 (de)
HK (1) HK1045468A1 (de)
MX (1) MXPA02006011A (de)
PT (2) PT1237608E (de)
SI (1) SI1237608T1 (de)
TW (2) TW470656B (de)
WO (2) WO2001043529A2 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1068401A (en) * 1999-10-12 2001-04-23 Shl Medical Ab Inhaler
US6668827B2 (en) * 2000-05-16 2003-12-30 Nektar Therapeutics Systems devices and methods for opening receptacles having a powder to be fluidized
GB2367756B (en) 2000-10-12 2003-01-08 Bespak Plc Dispensing apparatus
WO2002092154A1 (en) * 2001-04-26 2002-11-21 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
GB2375098B (en) 2001-04-30 2003-08-27 Bespak Plc Improvements in valves for pressurised dispensing containers
ITPG20010036A1 (it) * 2001-07-24 2003-01-24 Marco Cecchini Cartuccia autoforante per erogatori di polvere secche inalatorie
EP1450885B1 (de) 2001-09-28 2015-04-22 Kurve Technology, Inc. Nasaler vernebler
GB0128148D0 (en) * 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US20030168057A1 (en) * 2001-12-14 2003-09-11 Inhale Therapeutic Systems, Inc. Electronically controllable aerosol delivery
GB2384190A (en) 2002-01-22 2003-07-23 Bespak Plc Dispensing device for a powdered product
GR1004350B (el) * 2002-03-29 2003-09-26 Συσκευη εισπνοων ξηρης σκονης
AU2003249623A1 (en) 2002-05-09 2003-12-12 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
US6799571B1 (en) * 2002-06-19 2004-10-05 Molecular Rotation, Llc Medicinal powder delivery system
DE10244795A1 (de) * 2002-09-26 2004-04-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
US7559325B2 (en) * 2003-04-09 2009-07-14 Novartis Pharma Ag Aerosolization apparatus with air inlet shield
GB2405798A (en) 2003-09-15 2005-03-16 Vectura Ltd Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.
GB2410192B (en) * 2004-01-23 2005-12-07 Eg Technology Ltd An inhaler
DE102004012093A1 (de) * 2004-03-05 2005-09-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator mit Merkanaldüse
GB0407627D0 (en) * 2004-04-02 2004-05-05 Vectura Ltd Corkscrew pump
US7861712B2 (en) * 2004-04-23 2011-01-04 Manta Product Development Sealed capsule including an integrated puncturing mechanism
WO2006010248A1 (en) * 2004-07-26 2006-02-02 1355540 Ontario Inc. Powder inhaler featuring reduced compaction inhaler
GB0418738D0 (en) * 2004-08-23 2004-09-22 3M Innovative Properties Co Medicinal aerosol formulation receptacle and production thereof
GB0427028D0 (en) * 2004-12-09 2005-01-12 Cambridge Consultants Dry powder inhalers
GB0427858D0 (en) * 2004-12-20 2005-01-19 Glaxo Group Ltd Manifold for use in medicament dispenser
GB0427853D0 (en) * 2004-12-20 2005-01-19 Glaxo Group Ltd Manifold for use in medicament dispenser
AU2013201499B2 (en) * 2005-04-15 2015-01-15 Vectura Delivery Devices Limited Blister piercing element for dry powder inhaler
GB0507711D0 (en) * 2005-04-15 2005-05-25 Vectura Group Plc Improved blister piercing
US8763605B2 (en) 2005-07-20 2014-07-01 Manta Devices, Llc Inhalation device
GB0520794D0 (en) * 2005-10-12 2005-11-23 Innovata Biomed Ltd Inhaler
WO2007053878A1 (en) 2005-11-08 2007-05-18 Resmed Ltd Nasal assembly
ATE443658T1 (de) * 2005-11-21 2009-10-15 Mannkind Corp Pulverabgabe und -erfassungsvorrichtung und - verfahren
AR058290A1 (es) * 2005-12-12 2008-01-30 Glaxo Group Ltd Dispensador de medicamento
AR058289A1 (es) 2005-12-12 2008-01-30 Glaxo Group Ltd Colector para ser usado en dispensador de medicamento
DE102006014434A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Packmittel für Mehrdosispulverinhalatoren mit optimierten Entleerungseigenschaften
US8037880B2 (en) * 2006-04-07 2011-10-18 The University Of Western Ontario Dry powder inhaler
DE102006016903A1 (de) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
GB0611659D0 (en) * 2006-06-13 2006-07-19 Cambridge Consultants Dry powder inhalers
NZ576637A (en) * 2006-10-25 2012-05-25 Novartis Ag Powder dispersion apparatus with and mediciment receptacles that are cut open using an elliptical arc shaped knife blade oriented to yaw between 4 and 12 degrees
US9254370B2 (en) 2006-11-14 2016-02-09 Resmed Limited Frame and vent assembly for mask assembly
GB0700839D0 (en) * 2007-01-17 2007-02-21 Braithwaite Philip Device
US11224704B2 (en) 2007-07-06 2022-01-18 Manta Devices, Llc Dose delivery device for inhalation
EP3453418A1 (de) 2007-07-06 2019-03-13 Manta Devices, LLC Ausgabevorrichtung und zugehörige verfahren
EP2020249A1 (de) * 2007-08-01 2009-02-04 Boehringer Ingelheim Pharma GmbH & Co. KG Inhalator
ES2394589T3 (es) 2007-12-14 2013-02-04 Aerodesigns, Inc Suministro de productos alimenticios transformables en aerosol
EP2082763A1 (de) * 2008-01-24 2009-07-29 Boehringer Ingelheim International Gmbh Inhalator
ES2443300T3 (es) 2008-08-05 2014-02-18 Mannkind Corporation Módulos dispensadores de polvo y conjuntos dispensadores de polvo
US8550074B2 (en) 2009-01-15 2013-10-08 Manta Devices, Llc Delivery device and related methods
DK2515977T3 (en) 2009-12-26 2018-04-16 Inspiro Medical Ltd DEVICE FOR DELIVERY OF DRY POWDER
WO2011116293A2 (en) 2010-03-19 2011-09-22 Manta Devices, Llc Delivery device and related methods
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
JOP20120023B1 (ar) 2011-02-04 2022-03-14 Novartis Ag صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية
US11103659B2 (en) 2011-07-06 2021-08-31 Manta Devices, Llc Delivery device and related methods
US9649454B2 (en) 2012-05-03 2017-05-16 Manta Devices, Llc Delivery device and related methods
DE102012107767A1 (de) * 2012-08-23 2014-02-27 Rpc Formatec Gmbh Verfahren zum Entleeren einer Kavität und Vorrichtung zum Entleeren einer Kavität
GB201301192D0 (en) 2013-01-23 2013-03-06 Vectura Delivery Devices Ltd A blister piercing element for a dry powder inhaler
US9452139B2 (en) 2013-03-14 2016-09-27 Novartis Ag Respirable agglomerates of porous carrier particles and micronized drug
EP2968110A1 (de) 2013-03-14 2016-01-20 Novartis AG Deamorphisierung sprühgetrockneter formulierungen mittels sprühmischung
NO2709641T3 (de) 2014-03-10 2018-05-12
WO2015168572A2 (en) 2014-05-02 2015-11-05 Manta Devices, Llc Delivery device and related methods
EP3223891B1 (de) * 2014-11-26 2018-09-05 Vectura Delivery Devices Limited Öffnungsvorrichtung für blisterverpackungen in einem trockenpulverinhalator
USD796115S1 (en) * 2015-02-25 2017-08-29 AM-Tuotanto Oy Hair fiber sprayer
USD796738S1 (en) * 2015-02-25 2017-09-05 AM-Tuotanto Oy Hair fiber sprayer
CN105833399B (zh) * 2015-03-21 2018-11-09 深圳百美酶生物医药科技有限公司 手动干粉吸入器

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3967761A (en) † 1974-04-08 1976-07-06 Southwest Research Institute System for injecting particulate material into the combustion chamber of a repetitive combustion coating apparatus
US3980074A (en) † 1973-07-18 1976-09-14 Beecham Group Limited Device for the administration of powders
WO1996009085A1 (en) † 1994-09-21 1996-03-28 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US5622166A (en) † 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
CA2316345A1 (en) † 1997-12-22 1999-07-01 Alfred Von Schuckmann Device for inhaling powdered substances
EP1106196A2 (de) † 1999-12-10 2001-06-13 Unisia Jecs Corporation Inhalationsapparat

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US478744A (en) 1892-07-12 William james evans
US513189A (en) 1894-01-23 Powder-blower
US2603216A (en) 1952-07-15 Powder inhaler
US2533065A (en) 1947-03-08 1950-12-05 George V Taplin Micropulverized therapeutic agents
US2570774A (en) 1947-10-21 1951-10-09 Frank P C Davis Insufflator
US2549303A (en) 1949-04-20 1951-04-17 Bristol Lab Inc Inhaler for crystalline pencilllin or the like
US3425600A (en) 1966-08-11 1969-02-04 Abplanalp Robert H Pressurized powder dispensing device
US3809084A (en) * 1970-02-16 1974-05-07 American Cyanamid Co Pressurized portable dispenser
FR2224175B1 (de) * 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
GB1478138A (en) * 1973-07-18 1977-06-29 Beecham Group Ltd Device for the administration of powders
GB1479283A (en) 1973-07-23 1977-07-13 Bespak Industries Ltd Inhaler for powdered medicament
DE2346914C3 (de) 1973-09-18 1980-10-16 Paul Ritzau Pari-Werk, Gmbh & Co, 8130 Starnberg Inhalator für pulverförmige Substanzen
IT1016489B (it) 1974-03-18 1977-05-30 Isf Spa Inalatore
SU628930A1 (ru) 1974-11-26 1978-10-25 Московский научно-исследовательский институт туберкулеза Устройство дл введени порошкообразного лекарственного вещества
GB1521000A (en) 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
US3994421A (en) 1975-09-29 1976-11-30 American Cyanamid Company Unitary therapeutic aerosol dispenser
SE408265B (sv) 1975-12-12 1979-06-05 Draco Ab Anordning for koldioxiddriven endosaerosol, avsedd for inhalering
US4018185A (en) 1975-12-15 1977-04-19 Coors Container Company Powder feeder pick-up tube
NL7712041A (en) 1977-11-01 1979-05-03 Handelmaatschappij Voorheen Be Suction equipment for powdery material - incorporates ejector type suction pump and cyclone type separator
DE2960616D1 (en) 1978-05-03 1981-11-12 Fisons Plc Inhalation device
SU1003926A1 (ru) 1979-01-24 1983-03-15 Всесоюзный Научно-Исследовательский И Конструкторский Институт Автогенного Машиностроения Порошковый питатель
IT1116047B (it) 1979-04-27 1986-02-10 Sigma Tau Ind Farmaceuti Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma
JPS57500862A (de) 1979-10-30 1982-05-20
ES506585A0 (es) 1980-10-30 1982-09-01 Riker Laboratories Inc Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
US4548524A (en) * 1982-07-22 1985-10-22 Calumet Manufacturing Co. Dispensing package with applicator surface
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
CA1224992A (en) 1982-10-08 1987-08-04 Robert E. Newell Device for administering medicament to patients
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3345722A1 (de) 1983-12-17 1985-06-27 Boehringer Ingelheim KG, 6507 Ingelheim Inhalator
FR2575678B1 (fr) 1985-01-04 1988-06-03 Saint Gobain Vitrage Ejecteur pneumatique de poudre
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
FI88112C (fi) 1985-07-30 1993-04-13 Glaxo Group Ltd Anordning foer administrering av laekemedel till patienter
JPS63134270A (ja) * 1986-11-26 1988-06-06 Alps Electric Co Ltd プリンタの紙送り制御方法
IT1222509B (it) 1987-08-17 1990-09-05 Miat Spa Insufflatore per la somministrazione di farmaci sotto forma di polvere predosata in opercoli
GB8804069D0 (en) 1988-02-22 1988-03-23 Britains Petite Ltd Dispensers for powdered medication
IT1217890B (it) 1988-06-22 1990-03-30 Chiesi Farma Spa Dispositivo per l'inalazione di aerosol dosati
US4984158A (en) 1988-10-14 1991-01-08 Hillsman Dean Metered dose inhaler biofeedback training and evaluation system
DK479189D0 (da) 1989-01-06 1989-09-28 Hans Gernot Schenk Inhalator
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US5239991A (en) * 1989-06-21 1993-08-31 Fisons Plc Disposable powder medicament inhalation device with peel-off cover
IT1230313B (it) 1989-07-07 1991-10-18 Somova Spa Inalatore per medicamenti in capsule.
DE3927170A1 (de) 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
DE4004904A1 (de) 1990-02-16 1990-09-13 Gerhard Brendel Trommel-applikator
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
US5037912A (en) 1990-07-26 1991-08-06 The Goodyear Tire & Rubber Company Polymerization of 1,3-butadiene to trans-1,4-polybutadiene with organolithium and alkali metal alkoxide
DE4027749A1 (de) 1990-09-01 1992-03-05 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung fuer medien
US5042472A (en) * 1990-10-15 1991-08-27 Merck & Co., Inc. Powder inhaler device
US5217004A (en) 1990-12-13 1993-06-08 Tenax Corporation Inhalation actuated dispensing apparatus
EP0585379B1 (de) 1991-05-21 1998-09-30 Abbott Laboratories Aerosolinhalationsvorrichtung
IT1248059B (it) * 1991-06-14 1995-01-05 Miat Spa Insufflatore multidose per farmaci in polvere
ES2141108T3 (es) 1991-07-02 2000-03-16 Inhale Inc Metodo y dispositivo para proporcionar medicamentos en aerosol.
JP2914826B2 (ja) * 1991-07-22 1999-07-05 株式会社大協精工 衛生品用容器
US5337740A (en) 1991-08-01 1994-08-16 New England Pharmaceuticals, Inc. Inhalation devices
US5287850A (en) 1991-08-20 1994-02-22 Habley Medical Technology Corporation Timing and velocity controlled powered pharmaceutical inhaler
DE4128295A1 (de) 1991-08-27 1993-03-04 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung fuer fliessfaehige medien
GB9123953D0 (en) 1991-11-12 1992-01-02 Minnesota Mining & Mfg Inhalation device
DE4211475A1 (de) * 1991-12-14 1993-06-17 Asta Medica Ag Pulverinhalator
US5186166A (en) 1992-03-04 1993-02-16 Riggs John H Powder nebulizer apparatus and method of nebulization
US5355872B1 (en) 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
US5280287A (en) * 1992-06-30 1994-01-18 The United States Of America As Represented By The Secretary Of The Navy Coded identification and positioning system
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
WO1994006498A1 (en) 1992-09-23 1994-03-31 Fisons Plc Inhalation device
JP2578684Y2 (ja) * 1992-10-08 1998-08-13 四国化工機株式会社 粉粒体の計量充填装置
BR9307270A (pt) 1992-10-19 1999-06-01 Dura Pharma Inc Inalador de pó seco
KR960701672A (ko) * 1993-03-03 1996-03-28 윌리엄 피. 알트만 건조 분말 흡입기의 약제 캐리어(dry powder inhalator medicament carrier)
US5497763A (en) * 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
US5533502A (en) 1993-05-28 1996-07-09 Vortran Medical Technology, Inc. Powder inhaler with aerosolization occurring within each individual powder receptacle
US5349947A (en) 1993-07-15 1994-09-27 Newhouse Michael T Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
US5524613A (en) 1993-08-25 1996-06-11 Habley Medical Technology Corporation Controlled multi-pharmaceutical inhaler
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
IT1266794B1 (it) * 1993-11-09 1997-01-21 Faustino Ballini Dispositivo a doccia micronizzata per il lavaggio delle cavita' nasali e limitrofe
US5505194A (en) 1994-03-23 1996-04-09 Abbott Laboratories Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
JP3388896B2 (ja) * 1994-08-08 2003-03-24 株式会社日立ユニシアオートモティブ 吸入式投薬器
JP3308425B2 (ja) * 1995-03-10 2002-07-29 株式会社ユニシアジェックス 鼻腔用投薬器
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
AU706195B2 (en) * 1995-04-14 1999-06-10 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
EP0782867B1 (de) * 1995-07-25 2005-01-26 Teijin Limited Dosiervorrichtung für pulverförmige medikamente
JP3317827B2 (ja) * 1995-10-09 2002-08-26 株式会社ユニシアジェックス 投薬器
JPH09253208A (ja) * 1996-03-21 1997-09-30 Unisia Jecs Corp 鼻腔用投薬器
US5875776A (en) * 1996-04-09 1999-03-02 Vivorx Pharmaceuticals, Inc. Dry powder inhaler
DE19619536A1 (de) * 1996-04-25 1997-10-30 Alfred Von Schuckmann Inhalier-Vorrichtung
IT240641Y1 (it) * 1996-05-08 2001-04-02 Inge Spa Flacone per la conservazione separata di sostanze e la successivaerogazione a gocce della miscela di dette sostanze
US6103270A (en) * 1996-06-07 2000-08-15 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
DE19647947A1 (de) * 1996-11-20 1998-05-28 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung für Medien
SE9700421D0 (sv) * 1997-02-07 1997-02-07 Astra Ab Single dose inhaler I
SE9700423D0 (sv) * 1997-02-07 1997-02-07 Astra Ab Disposable inhaler
SE9700424D0 (sv) * 1997-02-07 1997-02-07 Astra Ab Powder inhaler
SE9700422D0 (sv) * 1997-02-07 1997-02-07 Astra Ab Single dose inhaler II
DE19704849B4 (de) * 1997-02-08 2011-02-17 Ing. Erich Pfeiffer Gmbh Austragvorrichtung für Medien
DE19817417A1 (de) * 1998-04-18 1999-10-21 Pfeiffer Erich Gmbh & Co Kg Spender für Medien, insbesondere Pulver
US6257233B1 (en) * 1998-06-04 2001-07-10 Inhale Therapeutic Systems Dry powder dispersing apparatus and methods for their use
US6012442A (en) * 1998-10-29 2000-01-11 Faraj; Abdul-Razzak Outdoor grill
US6606992B1 (en) * 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980074A (en) † 1973-07-18 1976-09-14 Beecham Group Limited Device for the administration of powders
US3967761A (en) † 1974-04-08 1976-07-06 Southwest Research Institute System for injecting particulate material into the combustion chamber of a repetitive combustion coating apparatus
WO1996009085A1 (en) † 1994-09-21 1996-03-28 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US5622166A (en) † 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system
CA2316345A1 (en) † 1997-12-22 1999-07-01 Alfred Von Schuckmann Device for inhaling powdered substances
EP1106196A2 (de) † 1999-12-10 2001-06-13 Unisia Jecs Corporation Inhalationsapparat

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0143529A2 †

Also Published As

Publication number Publication date
TW480183B (en) 2002-03-21
AU782677B2 (en) 2005-08-18
EP1237608B2 (de) 2010-05-19
AU2580101A (en) 2001-06-25
US6679256B2 (en) 2004-01-20
WO2001043529A2 (en) 2001-06-21
TW470656B (en) 2002-01-01
DE60032173T2 (de) 2007-09-27
PT1726323E (pt) 2011-05-25
EP1726323A2 (de) 2006-11-29
WO2001043530A2 (en) 2001-06-21
EP1726323B1 (de) 2011-02-23
CA2393615C (en) 2006-05-30
CA2393615A1 (en) 2001-06-21
US20050056275A1 (en) 2005-03-17
US20010029948A1 (en) 2001-10-18
AU2727901A (en) 2001-06-25
SI1237608T1 (sl) 2007-04-30
ES2363713T3 (es) 2011-08-12
PT1237608E (pt) 2007-02-28
DE60032173D1 (de) 2007-01-11
ES2274817T5 (es) 2010-12-03
DE60032173T3 (de) 2010-12-30
ATE499131T1 (de) 2011-03-15
ATE346636T1 (de) 2006-12-15
EP1237608B1 (de) 2006-11-29
WO2001043529A3 (en) 2002-05-10
DE60045670D1 (de) 2011-04-07
ES2274817T3 (es) 2007-06-01
WO2001043529A9 (en) 2002-12-27
CY1105993T1 (el) 2011-04-06
HK1045468A1 (zh) 2002-11-29
KR20020071888A (ko) 2002-09-13
US20010029947A1 (en) 2001-10-18
EP1726323A3 (de) 2007-08-22
DK1237608T3 (da) 2007-04-10
MXPA02006011A (es) 2003-01-28
WO2001043530A3 (en) 2001-11-29
JP2003516780A (ja) 2003-05-20

Similar Documents

Publication Publication Date Title
CA2393615C (en) Receptacles to facilitate the extraction of powders
US6668827B2 (en) Systems devices and methods for opening receptacles having a powder to be fluidized
US5785049A (en) Method and apparatus for dispersion of dry powder medicaments
EP1628698B1 (de) Medikamentenbehälter
CA2404225C (en) Medicament container with same side airflow inlet and outlet and method of use
JP3790423B2 (ja) 薬剤のデリバリの引き金となる吸入活性化流れ分割手段を有する乾燥粉末薬剤吸入器
AU2001249773A1 (en) Medicament container with same side airflow inlet and outlet and method of use
WO2002092154A1 (en) Metered dose delivery device for liquid and powder agents
AU2005203078B2 (en) Receptacles to facilitate the extraction of powders

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020701

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL PAYMENT 20020701;LT PAYMENT 20020701;LV PAYMENT 20020701;MK PAYMENT 20020701;RO PAYMENT 20020701;SI PAYMENT 20020701

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CLARK, ANDREW

Inventor name: PABOOJIAN, STEVE

Inventor name: SCHULER, CARLOS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NEKTAR THERAPEUTICS

17Q First examination report despatched

Effective date: 20041223

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60032173

Country of ref document: DE

Date of ref document: 20070111

Kind code of ref document: P

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20070115

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: KELLER & PARTNER PATENTANWAELTE AG

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20070400395

Country of ref document: GR

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2274817

Country of ref document: ES

Kind code of ref document: T3

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

26 Opposition filed

Opponent name: QUADRANT DRUG DELIVERY LIMITED

Effective date: 20070823

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

NLR1 Nl: opposition has been filed with the epo

Opponent name: QUADRANT DRUG DELIVERY LIMITED

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: NEKTAR THERAPEUTICS

NLT2 Nl: modifications (of names), taken from the european patent patent bulletin

Owner name: NEKTAR THERAPEUTICS

Effective date: 20071226

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1045468

Country of ref document: HK

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CY

Payment date: 20081112

Year of fee payment: 9

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: NOVARTIS AG

NLT2 Nl: modifications (of names), taken from the european patent patent bulletin

Owner name: NOVARTIS AG

Effective date: 20091028

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20091207

Year of fee payment: 10

Ref country code: MC

Payment date: 20091127

Year of fee payment: 10

Ref country code: LU

Payment date: 20091221

Year of fee payment: 10

Ref country code: IE

Payment date: 20091215

Year of fee payment: 10

Ref country code: FI

Payment date: 20091214

Year of fee payment: 10

Ref country code: DK

Payment date: 20091211

Year of fee payment: 10

PUAH Patent maintained in amended form

Free format text: ORIGINAL CODE: 0009272

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT MAINTAINED AS AMENDED

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091231

27A Patent maintained in amended form

Effective date: 20100519

AK Designated contracting states

Kind code of ref document: B2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

REG Reference to a national code

Ref country code: CH

Ref legal event code: AEN

Free format text: AUFRECHTERHALTUNG DES PATENTES IN GEAENDERTER FORM

REG Reference to a national code

Ref country code: CH

Ref legal event code: PUE

Owner name: NOVARTIS AG

Free format text: NEKTAR THERAPEUTICS#150 INDUSTRIAL ROAD#SAN CARLOS, CA 94070 (US) -TRANSFER TO- NOVARTIS AG#LICHTSTRASSE 35#4056 BASEL (CH)

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

REG Reference to a national code

Ref country code: SE

Ref legal event code: RPEO

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20100401891

Country of ref document: GR

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20101007 AND 20101013

REG Reference to a national code

Ref country code: ES

Ref legal event code: DC2A

Effective date: 20101123

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100407

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20100819

LTLA Lt: lapse of european patent or patent extension

Effective date: 20101215

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101231

REG Reference to a national code

Ref country code: SI

Ref legal event code: KO00

Effective date: 20110729

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101216

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101215

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101215

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20130617

Year of fee payment: 14

Ref country code: GB

Payment date: 20131211

Year of fee payment: 14

Ref country code: AT

Payment date: 20131126

Year of fee payment: 14

Ref country code: CH

Payment date: 20131212

Year of fee payment: 14

Ref country code: DE

Payment date: 20131211

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20131213

Year of fee payment: 14

Ref country code: GR

Payment date: 20131114

Year of fee payment: 14

Ref country code: FR

Payment date: 20131209

Year of fee payment: 14

Ref country code: NL

Payment date: 20131210

Year of fee payment: 14

Ref country code: ES

Payment date: 20131112

Year of fee payment: 14

Ref country code: TR

Payment date: 20131119

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20131217

Year of fee payment: 14

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: NEW ADDRESS: EIGERSTRASSE 2 POSTFACH, 3000 BERN 14 (CH)

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20150615

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141231

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60032173

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20150701

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20150701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150615

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 346636

Country of ref document: AT

Kind code of ref document: T

Effective date: 20141215

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20141215

REG Reference to a national code

Ref country code: GR

Ref legal event code: ML

Ref document number: 20100401891

Country of ref document: GR

Effective date: 20150722

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20150831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150701

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141215

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141215

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150722

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141215

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20160128

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141216

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141215